DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Mueller V, Paplomata E, Hamilton EP. et al.
Impact of tucatinib on health-related quality of life (HRQoL) in patients with HER2+ metastatic breast cancer (MBC) with and without brain metastases (BM).
Ann Oncol 2020;
31 (Suppl. 04) S348-S395
doi:10.1016/annonc/annonc268
We do not assume any responsibility for the contents of the web pages of other providers.